Skip to Main Content

Paper Details

PARP inhibitors, use early in the first-line maintenance therapy setting but with caution.
Ann Transl Med
1
2023
Author NameAffiliation
Yong-Man KimGynecologic Cancer Center, Asan Cancer Institute, Asan Medical Center, University of Ulsan
  • 1 - 1

Datasets

Release 1.2